PNC FINANCIAL SERVICES GROUP, INC. - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 8 filers reported holding Astellas Pharma Inc in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PNC FINANCIAL SERVICES GROUP, INC. ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q3 2023$2,299
-10.1%
166
-3.5%
0.00%
Q2 2023$2,557
+20.5%
172
+14.7%
0.00%
Q1 2023$2,122
+12.5%
150
+21.0%
0.00%
Q4 2022$1,886
-52.8%
124
-60.6%
0.00%
Q3 2022$4,000
+33.3%
315
+118.8%
0.00%
Q2 2022$3,000
+200.0%
144
+234.9%
0.00%
Q1 2022$1,0000.0%43
+22.9%
0.00%
Q4 2021$1,0000.0%350.0%0.00%
Q3 2021$1,000
-98.0%
35
-99.1%
0.00%
Q1 2017$50,000
-2.0%
3,811
+3.3%
0.00%
Q4 2016$51,000
-12.1%
3,690
-1.5%
0.00%
Q3 2016$58,0003,7460.00%
Other shareholders
Astellas Pharma Inc shareholders Q1 2023
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders